Emyria |
Market Cap (5-Nov) $30,654,068 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (29-Oct) 161,639 (0.02%) (557th) |
|
52w High $0.078 |
52w Low $0.036 |
P/E - |
EPS -0.01 |
Emyria Receives Ethics Approval for MDMA-assisted Therapy
EMD released this announcement to the ASX on 8 June 2023, 9:10. The announcement is marked as price sensitive, and is 4 page(s) in length and 717.18kb in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.004% short sold according to ASIC data. It was ranked the 574th most shorted stock on the ASX. It is now ranked as the 557th most shorted stock on the ASX with 0.020% of total shares short sold as of the latest reported data (29 October 2026).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Application for quotation of securities - EMD | 10 May 2023, 18:26 |
| Notification regarding unquoted securities - EMD | 10 May 2023, 18:22 |
If you were already registered, log in here.